Joseph L. Goldstein - Sep 10, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Joseph L. Goldstein
Stock symbol
REGN
Transactions as of
Sep 10, 2021
Transactions value $
-$666,975
Form type
4
Date filed
9/13/2021, 04:01 PM
Previous filing
Jun 8, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $944K +2.48K +42.08% $380.95 8.37K Sep 10, 2021 Direct F1
transaction REGN Common Stock Sale -$1.61M -2.48K -29.62% $650.00 5.89K Sep 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.48K -100% $0.00* 0 Sep 10, 2021 Common Stock 2.48K $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.